Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)

Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)

US Patent 11406638 · Granted Aug 9, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of active agents for the treatment of progressive fibrosing intersti2025
Combination of active agents for the treatment of progressive fibrosing intersti2025
Combination of active agents for the treatment of progressive fibrosing intersti2025
Combination of active agents for the treatment of progressive fibrosing intersti2023
Combination of active agents for the treatment of progressive fibrosing intersti2023
Combination of active agents for the treatment of progressive fibrosing intersti2023
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2020
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2017
Substituted quinolines and their use as medicaments2015
Drug combinations containing PDE4 inhibitors and NSAIDs2015
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2015
Heterocycle-substituted piperazino-dihydrothienopyrimidines2015